Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Natalie Wall Fowlkes Image

      Natalie Wall Fowlkes, D.V.M., Ph.D., DACVP, DABT

      Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine

      About Dr. Natalie Fowlkes


      Read More

      Present Title & Affiliation

      Primary Appointment

      Associate Professor, Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Associate Professor, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas

      Education & Training

      Degree-Granting Education

      2018Louisiana State University, Baton Rouge, Louisiana, US, Veterinary and Biomedical Sciences, Ph.D
      2010Louisiana State University, Baton Rouge, Louisiana, US, Veterinary Medicine, DVM
      2006Louisiana State University, Baton Rouge, Louisiana, US, Animal Science, BS

      Postgraduate Training

      2015-2018Research Fellowship, Postdoctoral Fellowship in Experimental Medicine and Pathology (NIH T32), Louisiana State University School of Veterinary Medicine, Baton Rouge, Louisiana
      2010-2013Clinical Residency, Anatomic Pathology, Louisiana State University School of Veterinary Medicine, Baton Rouge, Louisiana

      Licenses & Certifications

      2022American Board of Toxicology
      2016American College of Veterinary Pathologists

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Veterinary Medicine and Surgery, UT MD Anderson Cancer Center, Houston, TX, 2024 - 2025

      Assistant Professor, Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - 2024

      Administrative Appointments/Responsibilities

      Director, DISCOVER Summer Research Program, Veterinary Medicine and Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

      Education Director (Department level), Veterinary Medicine and Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

      Other Professional Positions

      Associate Member, MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences (GSBS), Houston, TX, 2021 - 2026

      Intramural Institutional Committee Activities

      member, Technology Task Force, The University of Texas MD Anderson Cancer Center, 2026 - Present

      member, Institutional Animal Care and Use Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      member, Scientific Review Committee, The University of Texas MD Anderson Cancer Center, 2025 - Present

      Extramural Institutional Committee Activities

      Member, Faculty Senate Education Committee, The University of Texas MD Anderson Cancer Center, 2021 - Present

      Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2020 - Present

      Alternate Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2018 - 2020

      Editorial Activities

      Associate Editor, Frontiers in Veterinary Science, 2024 - Present

      Review Editor, Frontiers in Veterinary Science, 2020 - 2024

      Honors & Awards

      2017ACVP Young Investigator Award (Experimental Disease Division), American College of Veterinary Pathology
      2013Veterinary Pathology Scholarship Award, Charles Louis Davis, DVM Foundation for the Advancement of Veterinary and Comparative Pathology
      2010Bayer Excellence in Communication Award, LSU School of Veterinary Medicine
      2010Oncology Certificate of Excellence Award, LSU School of Veterinary Medicine
      2009LSU SCAVMA Bookstore Scholarship, LSU School of Veterinary Medicine

      Professional Memberships

      Society for Immunotherapy of Cancer

      2024 - Present

      United States and Canadian Academy of Pathology

      2024 - Present

      American Society of Clinical Oncology

      2022 - Present

      American Association of Cancer Research

      2022 - Present

      Society of Toxicologic Pathology

      2022 - Present

      American Board of Toxicology

      2022 - Present

      Digital Pathology Association

      2021 - Present

      American Association for Laboratory Animal Science

      2018 - Present

      American Society for Investigative Pathology

      2018 - Present

      American College of Veterinary Pathologists

      2016 - Present

      Charles Louis Davis and Samuel Wesley Thompson DVM Foundation for The International Advancement of Education in Veterinary and Comparative Pathology

      2013 - Present

      Phi Zeta Honor Society

      2010 - Present

      American Veterinary Medical Association

      2010 - Present

      Selected Presentations & Talks

      Local Presentations

      1. 2024. Exploring the Role of CXCR2 in Brain Metastasis in Murine Models of Inflammatory Breast Cancer Using Multiplex Immunofluorescence. Poster. CATALYST Summer Student Syposium. Houston, Texas, US.
      2. 2024. Clinicopathologic Evaluation of Radiation-Induced Skin Toxicity in a Porcine Model. Poster. CATALYST Summer Student Symposium. Houston, Texas, US.
      3. 2023. Inflammatory Pseudotumors Induced by AdCre in Transgenic Oncopigs After In Situ Tumor Induction. Poster. CATALYST Summer Student Symposium. Houston, Texas, US.
      4. 2023. Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth in Preclinical PDX Models. Poster. CATALYST Summer Student Symposium. Houston, Texas, US.
      5. 2023. Tumor Stiffness is Associated with Reduced CD45+ Immune Cell Penetration of Tumors in a Rat Hepatocellular Carcinoma Model. Poster. CATALYST Summer Student Symposium. Houston, Texas, US.
      6. 2022. Clinicopathologic characterization of a multi-organ in situ tumor induction strategy in an oncopig model. Poster. Summer Experience Symposium. Houston, TX, US.
      7. 2022. Tungsten nanoparticle and polymer blends as novel coating for radiopaque resorbable inferior vena cava filter. Poster. Summer Experience Research Symposium. Houston, TX, US.
      8. 2022. CCR7 immune cell receptor expression in inflammatory breast cancer. Poster. Summer Experience Symposium. Houston, TX, US.

      Regional Presentations

      1. 2024. Neuropathologic Analysis of IL-15-Engineered NK Cell Therapy in a Murine Glioblastoma Model. Conference. Texas A&M Veterinary Medical Scientist Research Training Program Symposiun. College Station, TX, US.
      2. 2022. CCR7 expression in inflammatory breast cancer. Poster. San Antonio Breast Cancer Symposium, US.
      3. 2022. Struvite urolithiasis in a Tg(KRT14-cre)1Amc/J mouse. Poster. Texas Branch of the American Association of Laboratory Animal Science (TBAALAS), US.
      4. 2017. Evaluation of the HSV-1 Live-Attenuated VC2 Vaccine Strain as Oncolytic Immunomodulatory Virotherapy in a Murine Melanoma Model. Poster. Phi Zeta Research Emphasis Day. Baton Rouge, LA, US.
      5. 2017. Leiomyosarcoma in a Captive Tiger (Panthera tigris). Poster. Phi Zeta Research Emphasis Day. Baton Rouge, LA, US.
      6. 2017. Characterization of immune responses during tumor progression versus engraftment failure in a novel, immunocompetent double-labeled murine melanoma model. Conference. Louisiana Biomedical Research Network (LBRN) Summer Research Program. Baton Rouge, LA, US.
      7. 2017. Development of a novel immunocompetent murine melanoma model using double-labeled B16F10 murine melanoma cells. Conference. Louisiana Biomedical Research Network (LBRN) Summer Research Program. Baton Rouge, LA, US.
      8. 2012. Necrotizing fasciitis in a dog. Conference. Graduate Student Research Symposium. Baton Rouge, LA, US.
      9. 2011. A case of Hepatozoonosis and systemic amyloidosis in a dog. Conference. Graduate Student Symposium. Baton Rouge, LA, US.

      National Presentations

      1. 2024. Clinicopathologic Evaluation of Radiation-Induced Skin Toxicity in a Porcine Model. Poster. American College of Veterianry Pathologists. Seattle, WA, US.
      2. 2024. Neuropathologic Analysis of IL-15-Engineered NK Cell Therapy in a Murine Glioblastoma Model. Conference. American College of Veterinary Pathologists. Seattle, WA, US.
      3. 2024. ASCL2+ tumor cells modulate the response of colorectal cancer to MAPK targeting therapy. Poster. American Association of Cancer Research (AACR). San Diego, CA, US.
      4. 2024. Anti-CSF1R antibody monotherapy inhibits minimal residual disease in a novel immunocompetent murine colorectal cancer metastasis model. Poster. American Association of Cancer Research (AACR). San Diego, CA, US.
      5. 2024. Enhanced tumor control and survival in solid tumor models following combined low dose radiotherapy and T cell therapy. Poster. American Association of Cancer Research (AACR). San Diego, CA, US.
      6. 2024. Non-invasive monitoring of tumor biomechanics and implications for immunotherapy in HCC. Poster. American Association of Cancer Research (AACR). San Diego, CA, US.
      7. 2023. Pathologic Characterization of Adenovirus-Cre-induced Liver Lesions in Transgenic Oncopigs. Poster. American College of Veterinary Pathologists. Chicago, IL, US.
      8. 2023. Appendiceal Adenocarcinoma PDX Models Have Improved Tumor Growth in an Orthotopic Tumor Environment. Conference. American College of Veterinary Pathologists. Chicago, IL, US.
      9. 2023. A Rat Hepatocellular Carcinoma Model for Investigating Molecular Phenotypes Associated with Tumor Stiffness. Conference. American College of Veterinary Pathologists. Chicago, IL, US.
      10. 2023. Struvite Urolithiasis in a Tg(KRT14-cre)1Amc/J Mouse. Poster. American Association of Laboratory Animal Science (ALAAS). Salt Lake City, UT, US.
      11. 2023. Subacute Cutaneous Toxicity After Single-Fraction Electron FLASH RT in Yorkshire Swine. Conference. American Society for Radiation Oncology (ASTRO). San Diego, CA, US.
      12. 2023. Correlation of MR Imaging with Histology to Determine Anatomical Characteristics of the Breast Fascial System Using a Novel Cryo-Fluorescent Imager. Conference. American Association of Physicists in Medicine (AAPM). Houston, TX, US.
      13. 2023. Single-Fraction Electron Flash: Subacute Cutaneous Toxicity Analysis Via Swine Models. Conference. American Association of Physicists in Medicine (AAPM). Houston, TX, US.
      14. 2023. Mapping distribution of an alkylamine in tissue for restoration of an Immune-permissive microenvironment. Conference. American Society for Mass Spectrometry (ASMS). Santa Fe, NM, US.
      15. 2023. Initial Results from Mass Spectrometry Imaging Characterization of Liver Tumor Development in the Oncopig Model. Conference. American Society for Mass Spectrometry (ASMS). Santa Fe, NM, US.
      16. 2023. Feasibility Study of Alkaline Solutions in Embolotherapy. Conference. Global Embolization Symposium Technologies (GEST). New York City, NY, US.
      17. 2023. Initial Experience with an inducible transgenic tumor model in Swine. Conference. Global Embolization Symposium Technologies (GEST). New York City, NY, US.
      18. 2023. Preclinical Studies Using a Biopsy Tract Sealing and Fiducial Device. Conference. Global Embolization Symposium Technologies (GEST). New York City, NY, US.
      19. 2023. Vimentin content associated with shear wave speed in hepatocellular carcinoma: Non-invasive identification of more aggressive tumor phenotypes. Poster. American Association of Cancer Research (AACR). Orlando, FL, US.
      20. 2023. Recapitulating metastatic colorectal cancer in somatic mutation models for investigating the tumor immune microenvironment in minimal residual disease. Poster. American Association of Cancer Research (AACR). Orlando, FL, US.
      21. 2023. Modeling age-related changes in the tumor microenvironment in an orthotopic immunocompetent murine pancreatic cancer model-a novel approach. Poster. American Association of Cancer Research (AACR). Orlando, FL, US.
      22. 2023. Liver tumor or liver tumor? Initial Experience with the Oncopig for Hyperthermic Therapies. Conference. Society for Thermal Medicine (STM). San Diego, CA, US.
      23. 2023. Tuning Thermal and Ablative Effects of Acid Anhydrides in Thermoembolization. Conference. Society for Thermal Medicine (STM). San Diego, CA, US.
      24. 2023. Abstract No. 273 In Vivo Imaging of Novel Tungsten Nanoparticle and Polymer-Infused Resorbable Inferior Vena Cava Filters in Porcine Model. Conference. Society for Interventional Radiology (SIR). Phoenix, AZ, US.
      25. 2023. Abstract No. 31 Bioresorbable Mesenchymal Stem Cell-Loaded Electrospun Polymeric Scaffold Inhibits Neointimal Hyperplasia in a Rat Model of Arteriovenous Fistula. Conference. Society of Intervential Radiology (SIR). Phoenix, AZ, US.
      26. 2023. Antitumor activity of intraperitoneal (IP) paclitaxel to mucinous appendiceal adenocarcinoma in orthotopic patient-derived xenograft model. Poster. American Association of Clinical Oncology (ASCO). San Francisco, CA, US.
      27. 2022. Abstract P2-26-15: CCR7 expression in Inflammatory breast cancer. Poster. AACR San Antonio Breast Cancer Symposium. San Antonio, TX, US.
      28. 2022. Development of multiplex immunofluorescent panels for studying the immunobiology of metastatic colorectal cancer and minimal residual disease. Poster. American College of Veterinary Pathologists (ACVP). Boston, MA, US.
      29. 2022. Modeling age-related changes in the tumor microenvironment in an immunocompetent orthotopic murine pancreatic cancer model-a novel approach. Poster. American College of Veterinary Pathologists (ACVP). Boston, MA, US.
      30. 2022. Hepatic histiocytic proliferation arising in an immunocompetent murine model of colorectal cancer. Poster. American College of Veterinary Pathologists (ACVP). Boston, MA, US.
      31. 2022. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[18F]Fluoroglutamine. Conference. World Molecular Imaging Congress. Miami, FL, US.
      32. 2022. Somatic mutation models recapitulating metastatic colorectal cancer to study tumor immune microenvironment in minimal residual disease. Poster. Mechanisms and Models of Disease. Long Island, NY, US.
      33. 2022. Aurora kinase is an actionable target in low molecular weight cyclin E induced mammary tumors. Poster. American Association of Cancer Research (AACR). New Orleans, LA, US.
      34. 2022. Neutrophil elastase (NE) inhibition enhances metastasis free survival by altering regulation of tumor intrinsic cytoskeletal and cellular adhesion pathways in murine breast cancer models. Poster. American Association of Cancer Research (AACR). New Orleans, LA, US.
      35. 2022. LMW-E induction and crosstalk with immune cells potentiates local immune responses leading to an immunosuppressive microenvironment at the early stages of breast tumorigenesis in mouse models. Poster. American Association of Cancer Research (AACR). New Orleans, LA, US.
      36. 2022. Establishment of patient-derived xenografts in penile cancer. Poster. American Association of Cancer Research (AACR). New Orleans, LA, US.
      37. 2021. 45724 VC2 Oncolytic Virotherapy Induces Robust Systemic Anti-Tumor Immunity and Increases Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model. Conference. Association for Clinical and Translational Science (ACTS). Virtual, US.
      38. 2020. 531 AFM13-targeted blood and cord-blood-derived memory-like NK cells as therapy for CD30+ malignancies. Conference. Society for Immunotherapy of Cancer (SITC). Virtual, US.
      39. 2019. Cutaneous and Gastrointestinal Dysbiosis in Immunodeficient Mice. Conference. Experimental Biology (ASIP). Orlando, FL, US.
      40. 2016. Development of a syngeneic immunoompetent mouse model system for testing novel oncolytic herpes simplex virus type-1 for the treatment of melanoma. Conference. American College of Veterinary Pathologists (ACVP). New Orleans, LA, US.
      41. 2016. Development of a syngeneic immunocompetent mouse model system for testing novel oncolytic herpes simplex virus type-1 for teh treatment of melanoma. Poster. 41st Annual International Herpesvirus Workshop. Madison, WI, US.
      42. 2013. "Pathology of Lumps and Bumps". Invited. Student American Veterinary Medical Association. Baton Rouge, LA, US.
      43. 2012. A Neuropathology Mystery Solved (Angiostrongylus cantonensis). Conference. American College of Veterinary Patologists (ACVP). Seattle, WA, US.
      44. 2012. Evaluation of metomidate hydrochloride as an anesthetic in leopar frogs (|IRana pipiens). Conference. American Association of Zoo Veterinarians. Oakland, CA, US.
      45. 2012. Facial swelling in a horse (ameloblastic carcinoma). Conference. Southeastern Veterinary Pathology Conference. Tifton, GA, US.
      46. 2011. Renal leiomyosarcoma in a cat. Poster. American College of Veterinary Pathologists (ACVP). Nashville, TN, US.
      47. 2011. Sudden death in bearded dragons. Conference. Southeastern Veterinary Pathology Conference. Tifton, GA, US.

      International Presentations

      1. 2023. Examining the acute and long-tern response of normal tissue irradiated in FLASH and CONV RT. Conference. International Congress for Radiation Research (ICRR). Montreal, CA.
      2. 2017. A syngeneic immunocompetent double-labeled B16F10 murine melanoma model for efficacy and safety testing of oncolytic virotherapy using the HSV-1 VC2 live-attenuated vaccine strain. Conference. American College of Veterinary Pathologists (ACVP). Vancouver, CA.
      3. 2017. A syngeneic immunocompetent mouse model system for oncolytic virotherapy of metastatic melanoma using the HSV-1 VC2 live-attenuated vaccine strain. Conference. International Herpesvirus Workshop. Ghent, BE.
      4. 2013. Ichthyophonus-like disease in a Northern Leopard Frog (Rana pipiens). Conference. International Conference on Avian, Herpetological, and Exotic Mammal Medicine. Wiesbaden, DE.
      Read More
      Less

      Grant & Contract Support

      Date: 2025 - 2030
      Title:Nanoparticle- Infused Radiopaque Absorbable Medical Device
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2025 - 2028
      Title:A Novel Therapeutic Strategy Targeting Metastasis of Neuroendocrine Prostate Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      Date: 2024 - 2027
      Title:The Epigenetic Modifier UTX in HER2-positive Breast Cancer
      Funding Source:Department of Defense (DOD)
      Role:Other Significant Contributor
      Date: 2024 - 2029
      Title:KDM4A in the Metastasis of Neuroendocrine Prostate Cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2024 - 2027
      Title:Discovering Novel Oncoproteins Linked to KMT2D Loss in Gastric Adenocarcinoma
      Funding Source:Department of Defense (DOD)
      Role:Other Significant Contributor
      Date: 2024 - 2028
      Title:Targeting of Cancer Stem cells by inhibiting MELK in Aggressive Breast Cancers
      Funding Source:American Cancer Society (ACS)
      Role:Co-I
      Date: 2024 - 2029
      Title:Mesenchymal Stem Cell-Loaded Biopolymeric Scaffolds for Augmenting the Preoperative Liver Growth
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2024 - 2029
      Title:Identifying Novel Oncoproteins Linked to KMT2D Loss in Gastric Adenocarcinoma
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2024 - 2029
      Title:Multimodal Imaging to Determine Anatomical Characteristics of the Breast Fascial System
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2024 - 2029
      Title:Defining and Targeting Alterations of the Epigenetic Modifier KMT2D in Non-Small Cell Lung Cancer
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2024 - 2029
      Title:The Epigenetic Modifier JARID1D and its Corepressors in Regulation of Prostate Cancer Metastasis
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2024 - 2027
      Title:JARID1D and its Corepressors in Regulation of Prostate Cancer Metastasis
      Funding Source:Department of Defense (DOD)
      Role:Other Significant Contributor
      Date: 2024
      Title:Mechanisms of Cholesterol-Mediated and Radiation Resistance
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2024 - 2025
      Title:Role of MELK as a novel therapeutic target in aggressive breast cancers
      Funding Source:ELSA U PARDEE FOUNDATION
      Role:Co-I
      Date: 2024 - 2029
      Title:Oncogenic Role of Aberrant ZFY Expression in Medulloblastoma
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2024 - 2029
      Title:Toward Clinical Monitoring of Tumor Stromal Dynamics Using Integrated Quantitative Ultrasound Applications
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2024 - 2029
      Title:Translating advanced approaches to precision targeting of KRAS mutated cancers
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2024 - 2029
      Title:MELK as a Driver of Progression and Metastasis in Aggressive Breast Cancers
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2024
      Title:Transcatheter Chemistry: A Novel Approach In Image-Guided Therapy
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2024 - 2027
      Title:JARID1D and its Corepressors in Regulation of Prostate Cancer Metastasis
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Other Significant Contributor
      Date: 2024 - 2027
      Title:Targeting of Cancer Stem cells by inhibition of MELK in Aggressive Breast Cancers
      Funding Source:American Cancer Society (ACS)
      Role:Co-I
      Date: 2023 - 2030
      Title:Nanoparticle-Enhanced Absorbable Medical Devices for Management of Vascular Diseases
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2025
      Title:Targeted Reversal of Acidic pH in the Tumor Microenvironment
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2025
      Title:The Epigenetic Modifier UTX, Breast Cancer, and Drug Resistance
      Funding Source:Department of Defense (DOD)
      Role:Co-I
      Date: 2023 - 2024
      Title:Aberrant MLL4-ZFY Axis in Medulloblastoma
      Funding Source:Department of Defense (DOD)
      Role:Co-I
      Date: 2023 - 2028
      Title:Developing a novel combination immunotherapy for triple-negative breast cancer
      Funding Source:University of Hawaii Cancer Center
      Role:Co-I
      Date: 2023 - 2024
      Title:Developing Clinically Relevant Genetic Mouse Models for Upper Track Urothelial Cancer
      Funding Source:Department of Defense (DOD)
      Role:Co-I
      Date: 2023 - 2028
      Title:The Histone Modifier UTX in Triple-Negative and HER2-Positive Breast Cancer
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2023 - 2028
      Title:In Vivo Chemistry as a New Approach to Treat Solid Tumors
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2028
      Title:Developing a novel combination immunotherapy for triple-negative breast cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2028
      Title:Development of mutant PEA-15 as a novel therapeutic for triple-negative breast cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2028
      Title:MELK as a Driver of Progression and Metastasis in Aggressive Breast Cancers
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2028
      Title:Reactive Embolization for Selective and Effective Treatment of Solid Tumors
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2023 - 2028
      Title:The Histone Modifier UTX, Breast Cancer, and Drug Resistance
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2023 - 2028
      Title:In Vivo Chemistry as a New Approach to Treat Solid Tumors
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2023 - 2026
      Title:Enhancing Immune Responses in Pancreatic Cancer by Stromal Inhibition of HIF2
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      Date: 2023 - 2026
      Title:PEA-15 Gene Therapy for Aggressive Breast Cancers
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      Date: 2023 - 2026
      Title:The Epigenetic Modifier UTX, Breast Cancer, and Drug Resistance
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      Date: 2023 - 2025
      Title:Cis-aconitate decarboxylase (ACOD1) as a therapeutic target in immunosuppressive PMN-MDSC's
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Co-I
      Date: 2023 - 2026
      Title:Advanced approaches to understanding and targeting BRAF tumors
      Funding Source:Gastro-Intestinal Research Foundation
      Role:Collaborator
      ID:AWD0007261
      Date: 2023 - 2026
      Title:Targeting of Cancer Stem cells by inhibition of MELK in Aggressive Breast Cancers
      Funding Source:American Cancer Society (ACS)
      Role:Co-I
      Date: 2022 - 2024
      Title:Engineered Extracellular Vesicles to Modulate immunotherapy in Liver Cancer
      Funding Source:Society of Interventional Oncology
      Role:Co-I
      Date: 2022 - 2025
      Title:The Role of MELK in Stromal Reorganization of Aggressive Breast Cancers
      Funding Source:Department of Defense (DOD)
      Role:Co-I
      ID:BC220287
      Date: 2022 - 2027
      Title:Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2027
      Title:The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2027
      Title:Image-guided therapy for liver cancer
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2022 - 2027
      Title:KDM4A in the Metastasis of Neuroendocrine Prostate Cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2027
      Title:Translating FLASH Radiobiological Insights to Cutaneous Malignancies
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2023
      Title:Strategies to restore an immune-permissive microenvironment
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2022 - 2027
      Title:Heterozygous KMT2D Loss and Medulloblastoma
      Funding Source:NIH/NCI
      Role:Consult
      ID:1R01CA262324-01A1
      Date: 2022 - 2027
      Title:The Epigenetic Modifier UTX in Breast Cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2027
      Title:Epigenome reporgramming and targeting in aggressive variant prostate cancers
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2023
      Title:FLASH Radiation Therapy Optimization on Clinically Relevant Volumes of Pig Skin Using The IntraOp® Electron FLASH Mobetron® Designed for Clinical Use
      Funding Source:American Society for Therapeutic Radiology and Oncology (ASTRO)
      Role:Other Significant Contributor
      Date: 2022 - 2023
      Title:Determination of the Toxicity Equivalent Dose and Effective Fractionation Regimen For FLASH-RT on the IntraOp Mobetron Electron FLASH Unit Designed For Clinical Utilization
      Funding Source:Radiological Society of North America (RSNA)
      Role:Other Significant Contributor
      Date: 2022 - 2027
      Title:Biodegradable Radiopaque Polymeric Scaffolds Loaded with Mesenchymal Stem Cells for Image-Guided Arteriovenous Fistula Maturation and Long-Term Patency
      Funding Source:NIH/NCI
      Role:Co-I
      ID:1RO1HL159960-01A1
      Date: 2022 - 2024
      Title:Characterization of endovascular ablative therapies with computational modeling
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2027
      Title:Combining Heat, Hypoxia, Drugs, Reource Depletion, and Protons: A Disruptive Approach for Liver Cancer
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2022 - 2027
      Title:Therapeutic approaches for TGF-beta-enriched minimal residual disease in patients with colorectal cancer
      Funding Source:NIH/NCI
      Role:Co-I
      Date: 2022 - 2025
      Title:Elucidating the role of tumor-propagating cells in the response of colorectal cancer to MAPK-targeting therapy
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2022 - 2025
      Title:Therapeutic approaches for TGF-beta-enriched minimal residual disease in patients with colorectal cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      ID:RP220416
      Date: 2022 - 2025
      Title:Histone Modifiers and Enhancer Reprogramming in Prostate Cancer Metastasis
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      Date: 2021 - 2026
      Title:Fgl2 neutralizing therapy for inducing tumor specific brain resident immune memory against CNS tumor relapse
      Funding Source:NIH/NCI
      Role:Co-I
      ID:1R01NS122857-01
      Date: 2021 - 2022
      Title:Multi-modal imaging to characterize the spatiotemporal evolution of thermochemical ablation
      Funding Source:SIR FOUNDATION
      Role:Co-I
      Date: 2020 - 2022
      Title:Interactions of Menopausal Status, Adiposity and KRAS Mutation on Colorectal Cancer Biology
      Funding Source:Department of Defense (DOD)
      Role:Collaborator
      Date: 2020 - 2025
      Title:Use of Autologous Humanized Mouse Models to Model Immunotherapy in PIK3CA Colorectal Cancer Patient Derived Xenografts
      Funding Source:NIH/NCI
      Role:Collaborator
      Date: 2020 - 2023
      Title:Adiposity and Colorectal Cancer
      Funding Source:Cancer Prevention & Research Institute of Texas (CPRIT)
      Role:Collaborator
      Date: 2019 - 2024
      Title:Cancer Center Support (CORE) Grant
      Funding Source:NIH/NCI
      Role:Other Significant Contributor
      Date: 2019 - 2022
      Title:Tailoring CAR-based Immunotherapy Strategies to T Cell Lymphoma
      Funding Source:BCM/Stand Up to Cancer (SU2C)
      Role:Co-I
      Title:Humanized patient-derived xenografts: a co-clinical trial for MSS, BRAF V600E CRC
      Funding Source:MD Anderson SPORE in Gastrointestinal Cancer
      Role:Pathologist
      Title:IL-1-p62 Axis Regulation and Function in Castration Resistant PCa
      Funding Source:American Cancer Society (ACS)
      Role:Collaborator
      Title:Interleukin-1 Drives p62-Dependent androgen receptor independence in treatment resistant prostate cancer
      Funding Source:Department of Defense (DOD)
      Role:Collaborator
      Title:IL-1-p62 Axis Regulation and Function in Castration Resistant PCa
      Funding Source:NIH/NCI
      Role:Collaborator

      Selected Publications

      Peer-Reviewed Articles

      1. Boda, A, Bandey, I, Chowdhury, S, Aggarwal, S, Mekala, V, Fowlkes, NW, Anderson, A, Roszik, J, Curran, M, Morris, VK, Kopetz, S, Singh, M. IL1R1 blockade augments CD40 agonist mediated immunity in pancreatic cancer. Scientific reports 16(1), 2026. e-Pub 2026. PMID: 41935073.
      2. Chen, J, Balema, W, Krishnamurthy, S, Lawrence, AN, Fowlkes, NW, Larson, R, Shivhare, S, Sanchez, CI, Rodriguez, MM, Lee, J, Schlee Villodre, E, Debeb, BG, Ueno, NT, Van Laere, SJ, Bertucci, F, Cho, H, Sulman, EP, Lim, B, Woodward, W. CCR7 immune cell receptor expression in inflammatory breast cancer. Scientific reports 16(1), 2026. e-Pub 2026. PMID: 41832292.
      3. Lee, HM, Zheng, Z, Sorokin, A, Wong, CW, Napolitano, S, Chowdhury, S, Kanikarla Marie, P, Singh, AK, Kochat, V, Bristow, C, Srinivasan, S, Peoples, M, Arslan, E, Alshenaifi, J, Villarreal, OE, Morris, VK, Shen, JY, Meric-Bernstam, F, Jain, A, Fowlkes, NW, Anderson, A, Menter, DG, Saw, AK, Rai, K, Kopetz, S. Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF-Mutant Colorectal Cancer. Clinical Cancer Research 32(15):3309-3324, 2026. e-Pub 2026. PMID: 42101296.
      4. Pant, V, Moyer, SM, Mitheera, V, Wasylishen, A, Mirani, A, Fowlkes, NW, Lozano, G. The physiological relevance of downstream effectors of p53 activity. Proceedings of the National Academy of Sciences of the United States of America 123(25), 2026. e-Pub 2026. PMID: 42301774.
      5. Barcena, AR, Bernardino, MR, Bolinas, DM, Marco, KD, Marks, AE, Manalastas, TS, Mishra, A, Fowlkes, NW, Bouchard, RR, Cheng, J, Huang, SY, Melancon, MP. Transcriptomic profiling of radiopaque nanoparticle-loaded, bioresorbable polymeric perivascular wrap for arteriovenous fistula maturation. Biomedical Microdevices 28(2), 2026. e-Pub 2026. PMID: 42095925.
      6. Thege, F, Hoskins, A, Kramer, A, Salim, I, Seetharaman, A, Fowlkes, NW, Rajapakshe, K, Maitra, A, Woermann, SM. An autochthonous CRISPR activation screening platform for characterizing tissue-specific oncogene selection. Cell Reports Medicine 7(5), 2026. e-Pub 2026. PMID: 41999750.
      7. Hu, XD, Xiong, Y, Schlee Villodre, E, Zhang, H, Longa, IR, Song, J, Fowlkes, NW, Krishnamurthy, S, Rylander, MN, Bartholomeusz, C, Tripathy, D, Woodward, W, Chen, J, Debeb, BG. Soluble E-cadherin-CXCL1-CXCR2 axis as a therapeutic vulnerability in inflammatory breast cancer brain metastasis. Neuro-oncology 28(5):1220-1236, 2026. e-Pub 2026. PMID: 41578012.
      8. Cressman, EN, Hicks, SC, Fowlkes, NW, Stolley, D, Stenkamp, MS. Characterization of inflammatory pseudotumors in a large animal model of liver cancer. Animal Models and Experimental Medicine 9(2):344-353, 2026. e-Pub 2026. PMID: 41498244.
      9. Cressman, EN, Stolley, D, Warar, S, Fowlkes, NW, Fuentes, DA. A fundamentally new direction in embolization using reactive chemistry in a swine model. Scientific reports 15(1), 2025. e-Pub 2025. PMID: 40389472.
      10. Amare, R, Stolley, D, Parrish, S, Jacobsen, MC, Layman, RR, Santos, C, Rivière, B, Fowlkes, NW, Fuentes, DA, Cressman, EN. 1D thermoembolization model using CT imaging data for porcine liver. Scientific reports 15(1), 2025. e-Pub 2025. PMID: 40596406.
      11. Biederstädt, A, Basar, R, Park, JM, Uprety, N, Shrestha, R, Reyes Silva, F, Dede, M, Watts, J, Acharya, S, Xiong, D, Liu, B, Daher, M, Rafei, H, Banerjee, PP, Li, P, Islam, S, Fan, H, Shanley, M, Jin, J, Kumar, B, Woods, V, Lin, P, Tiberti, S, Nunez Cortes, Ak, Jiang, XR, Biederstädt, I, Zhang, P, Li, YE, Rawal, S, Liu, E, Muniz-Feliciano, L, Deyter, GM, Shpall, E, Fowlkes, NW, Chen, K, Rezvani, K. Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency. Cancer cell 43(11):2069-2088.e11, 2025. e-Pub 2025. PMID: 40845844.
      12. San Valentin, ED, Damasco, J, Bernardino, MR, Mishra, A, Barcena, AR, Bolinas, DM, Canlas, GM, Jacobsen, MC, Layman, RR, Chintalapani, G, Norton, W, Fowlkes, NW, Chen, SR, Huang, SY, Melancon, MP. Gadolinium nanoparticle-enhanced, radiopaque, and resorbable inferior vena cava filters for improved in vivo applications. Acta Biomaterialia 207:342-352, 2025. e-Pub 2025. PMID: 41115622.
      13. Morad, G, Damania, A, Melendez, B, Singh, BB, Veguilla, FJ, Soto, RA, Hoballah, YM, Sahasrabhojane, P, Wong, M, Ahmed, M, Rico, R, Lewis, KN, Wani, K, Shamsutdinova, D, Lazcano Segura, RN, Ingram, D, Goethe, E, Day, A, Flores, I, McDaniel, L, Chelvanambi, M, Johnson, S, Dimitriou, F, Gupta, P, Oberai, S, Zal, MA, Doss, P, Jamal, MA, Hayase, E, Wathoo, C, Norberg, L, Jenkins, SL, Nass, S, Gumin, J, Long, L, Yang, J, Bradley, GR, Bekal, MP, Dono, A, Pichardo-Rojas, PS, Andrewes, S, Ballester, L, Losh, JS, Liang, J, Huo, L, Nielsen, D, Parker Kerrigan, BC, Brastianos, PK, Fowlkes, NW, Chang, C, Jenq, RR, Gomez-Manzano, C, Huse, J, Davies, MA, Lazar, A, Bhat, KP, Tandon, N, Esquenazi, Y, Peterson, CB, Puduvalli, VK, Lang Jr, FF, Johnston, CD, Bullman, S, Ajami, NJ, Ferguson, SD, Wargo, J. Microbial signals in primary and metastatic brain tumors. Nature medicine 31(11):3675-3688, 2025. e-Pub 2025. PMID: 41238915.
      14. Millward, NZ, Ozambela, M, Karki, M, He, R, Chauhan, PK, Pesquera, P, Hernandez Gonzalez, AE, Ochoa, O, Pieretti, AC, Chen, H, de la Cerda, C, Yu, Z, Grover, A, Hicks-Peňa, S, Fowlkes, NW, Wang, L, Maity, T, Rao, P, Genovese, G, Tannir, NM, Karam, JA, Msaouel, P. Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase–Deficient Renal Cell Carcinoma. Molecular cancer therapeutics 24(11):1722-1732, 2025. e-Pub 2025. PMID: 40601845.
      15. Rafei, H, Basar, R, Acharya, S, Hsu, YS, Liu, P, Zhang, D, Bohn, T, Liang, Q, Mohanty, V, Upadhyay, R, Li, P, Phadatare, P, Dede, M, Xiong, D, Fan, H, Jones, C, Kunz, S, Daher, M, Nunez Cortes, AK, Shanley, M, Liu, B, Moseley, SM, Zhang, C, Fang, D, Banerjee, PP, Uprety, N, Li, YE, Shrestha, R, Wan, X, Shen, H, Woods, V, Gilbert, AL, Rawal, S, Dou, J, Tan, Y, Park, JM, Reyes Silva, F, Biederstädt, A, Kaplan, M, Jiang, XR, Biederstädt, I, Kumar, B, Tiberti, S, Moore, M, Jin, J, Yang, RZ, Muniz-Feliciano, L, Rosemore, S, Lin, P, Deyter, GM, Fowlkes, NW, Jain, A, Marin, D, Maitra, A, Chen, K, Bopp, T, Shpall, E, Rezvani, K. CREM is a regulatory checkpoint of CAR and IL-15 signalling in NK cells. Nature 643(8073):1076-1086, 2025. e-Pub 2025. PMID: 40468083.
      16. Cressman, EN, Stolley, D, Fowlkes, NW, Felix, E, Priebe, W, Parrish, S, Fuentes, DA. Harnessing Electrophiles In Vivo. Molecular Pharmaceutics 22(6):3010-3016, 2025. e-Pub 2025. PMID: 40359181.
      17. Nieto, Y, Banerjee, PP, Kaur, I, Basar, R, Li, YE, Daher, M, Rafei, H, Kerbauy, LN, Kaplan, M, Marin, D, Griffin, L, Barnett, M, Bassett Jr, R, Uprety, N, Shrestha, R, Silva, FR, Islam, S, Ganesh, C, Borneo, Z, Ramdial, JL, Ramirez, A, Hosing, C, Alousi, AM, Popat, UR, Qazilbash, MH, Ahmed, S, Iyer, SP, Sainz, TP, Vega Vazquez, F, Fowlkes, NW, Alexis, K, Emig, M, Harstrick, A, Overesch, A, Shpall, E, Rezvani, K. Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma. Nature medicine 31(6):1987-1993, 2025. e-Pub 2025. PMID: 40186077.
      18. Snoddy, E, Tang, TT, Fowlkes, NW, Huynh, T, Brewer Savannah, KJ, Contreras, A, Reece, GP, Brock, K. Development of an H&E on-block staining technique for collagen detection in cryo-fluorescence tomography imaging of frozen breast tissue samples. PloS one 20(6 June), 2025. e-Pub 2025. PMID: 40489534.
      19. Cressman, EN, Stolley, D, Fowlkes, NW, Warar, S, Felix, E, Priebe, W, Parrish, S, Fuentes, DA. Chemistry Outside the Flask. ACS Pharmacology and Translational Science 8(4):1087-1095, 2025. e-Pub 2025. PMID: 40242576.
      20. Bolinas, DM, Barcena, AR, Mishra, A, Bernardino, MR, Lin, V, Heralde, F, Chintalapani, G, Fowlkes, NW, Huang, SY, Melancon, MP. Mesenchymal Stem Cells Loaded in Injectable Alginate Hydrogels Promote Liver Growth and Attenuate Liver Fibrosis in Cirrhotic Rats. Gels 11(4), 2025. e-Pub 2025. PMID: 40277686.
      21. Ito, I, Pattalachinti, V, Yousef, A, Chowdhury, S, Fanaeian, M, Haque, EU, Gunes, BB, Yousef, M, Salle, ER, Zeineddine, MA, Ji, S, Li, R, Wang, W, Helmink, BA, Taggart, MW, White, MG, Fournier, KF, Fowlkes, NW, Shen, JY. Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma. ESMO Gastrointestinal Oncology 7, 2025. e-Pub 2025. PMID: 41069644.
      22. Li M, Lulla AR, Wang Y, Tsavaschidis S, Wang F, Karakas C, Nguyen TD, Bui TN, Pina MA, Chen M, Mastoraki S, Multani AS, Fowlkes NW, Sahin A, Marshall C, Hunt KK, Keyomarsi AK. Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer. Cancer Research 84(22):3864-3880, 2024. e-Pub 2024. PMID: 39186665.
      23. Smetanick, D, Stolley, D, Fuentes, DA, Fowlkes, NW, Shakoor, F, Stenkamp, MS, Hicks, SC, Parrish, S, Cressman, EN. Volumetric CT Assessment of In Situ Induced Hepatic Lesions in a Transgenic Swine Model. Life 14(11), 2024. e-Pub 2024. PMID: 39598194.
      24. Acharya S, Basar R, Daher M, Rafei H, Li P, Uprety N, Ensley E, Shanley M, Kumar B, Banerjee PP, Melo Garcia L, Lin P, Mohanty V, Kim KH, Jiang X, Pan Y, Li Y, Liu B, Nunez Cortes AK, Zhang C, Fathi M, Rezvan A, Montalvo MJ, Cha SL, Reyes-Silva F, Shrestha R, Guo X, Kundu K, Biederstadt A, Muniz-Feliciano L, Deyter GM, Kaplan M, Jiang XR, Liu E, Jain A, Roszik J, Fowlkes NW, Solis Soto LM, Raso MG, Khoury JD, Lin P, Vega F, Varadarajan N, Chen K, Marin D, Shpall EJ, Rezvani K. CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3zeta/ZAP70 Signaling Axis. Cancer Discov 14(10):1879-1900, 2024. e-Pub 2024. PMID: 38900051.
      25. Barcena AJR, Perez JVD, Bernardino MR, Damasco JA, San Valentin EMD, Klusman C, Martin B, Canlas GM, Heralde FM 3rd, Fowlkes N, Bouchard RR, Cheng J, Huang SY, Melancon MP. Bismuth-infused perivascular wrap facilitates delivery of mesenchymal stem cells and attenuation of neointimal hyperplasia in rat arteriovenous fistulas. Biomater Adv 166:214052, 2024. e-Pub 2024. PMID: 39341164.
      26. Amare R, Stolley D, Parrish S, Jacobsen M, Layman R, Santos C, Riviere B, Fowlkes N, Fuentes D, Cressman E. 1D Thermoembolization Model Using CT Imaging Data for Porcine Liver. ArXiv, 2024. e-Pub 2024. PMID: 39314502.
      27. Shanley, M, Daher, M, Dou, J, Li, S, Basar, R, Rafei, H, Dede, M, Gumin, J, Pantaleόn Garcίa, J, Nunez Cortes, AK, He, S, Jones, C, Acharya, S, Fowlkes, NW, Xiong, D, Singh, S, Shaim, H, Hicks, SC, Liu, B, Jain, A, Zaman, MF, Miao, Q, Li, YE, Uprety, N, Liu, E, Muniz-Feliciano, L, Deyter, GM, Mohanty, V, Zhang, P, Evans, S, Shpall, EJ, Lang Jr, FF, Chen, K, Rezvani, K. Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD. Cancer cell 42(8):1450-1466.e11, 2024. e-Pub 2024. PMID: 39137729.
      28. Barcena, AR, Perez, JD, Bernardino, MR, San Valentin, ED, Damasco, J, Klusman, C, Martin, B, Court, KA, Godin, B, Canlas, GM, Fowlkes, NW, Bouchard, RR, Cheng, J, Huang, SY, Melancon, MP. Controlled Delivery of Rosuvastatin or Rapamycin through Electrospun Bismuth Nanoparticle-Infused Perivascular Wraps Promotes Arteriovenous Fistula Maturation. ACS Applied Materials and Interfaces 16(26):33159-33168, 2024. e-Pub 2024. PMID: 38912610.
      29. Pattalachinti VK, Ito I, Chowdhury S, Yousef A, Gu Y, Gunes BB, Salle ER, Taggart MW, Fournier K, Fowlkes NW, Shen JP. Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Mol Cancer Res 22(4):329-336, 2024. e-Pub 2024. PMID: 38226984.
      30. Lulla AR, Akli S, Karakas C, Caruso JA, Warma LD, Fowlkes NW, Rao X, Wang J, Hunt KK, Watowich SS, Keyomarsi K. Neutrophil Elastase Remodels Mammary Tumors to Facilitate Lung Metastasis. Mol Cancer Ther 23(4):492-506, 2024. e-Pub 2024. PMID: 37796181.
      31. Hu Y, Revenko A, Barsoumian H, Bertolet G, Fowlkes NW, Maazi H, Green MM, He K, Sezen D, Voss TA, Leyton CSK, Masrorpour F, Rafiq Z, Puebla-Osorio N, Leuschner C, MacLeod R, Cortez MA, Welsh JW. Inhibition of MER proto-oncogene tyrosine kinase by an antisense oligonucleotide enhances treatment efficacy of immunoradiotherapy. J Exp Clin Cancer Res 43(1):70, 2024. e-Pub 2024. PMID: 38443968.
      32. Zacharias NM, Segarra L, Akagi K, Fowlkes NW, Chen H, Alaniz A, de la Cerda C, Pesquera P, Xi Y, Wang J, Chahoud J, Lu X, Rao P, Martinez-Ferrer M, Pettaway CA. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma. Cancers (Basel) 16(5), 2024. e-Pub 2024. PMID: 38473423.
      33. Kezar S, Fowlkes NW, Hensel ME. Nerve sheath tumor in the forearm of a common marmoset (Callithrix jacchus). J Med Primatol 53(1):e12659, 2024. e-Pub 2024. PMID: 37340582.
      34. Puebla-Osorio, N, Fowlkes, NW, Barsoumian, H, Xega, K, Srivastava, G, Kettlun Leyton, C, Nizzero, S, Voss, TA, Riad, TS, Wong, C, Huang, A, Hu, Y, Mitchell, JA, Kim, M, Rafiq, Z, He, K, Sezen, D, Hsu, EY, Masrorpour, F, Maleki, A, Leuschner, C, Cortez, MA, Oertle, P, Loparic, M, Plodinec, M, Markman, JL, Welsh, J. Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy. Frontiers in Oncology 14, 2024. e-Pub 2024. PMID: 39445067.
      35. San Valentin EM, Damasco JA, Bernardino M, Court KA, Godin B, Canlas GM, Melancon A, Chintalapani G, Jacobsen MC, Norton W, Layman RR, Fowlkes N, Chen SR, Huang SY, Melancon MP. Image-Guided Deployment and Monitoring of a Novel Tungsten Nanoparticle-Infused Radiopaque Absorbable Inferior Vena Cava Filter in a Swine Model. J Vasc Interv Radiol 35(1):113-121.e3, 2024. e-Pub 2024. PMID: 37696432.
      36. Puebla-Osorio N, Fowlkes NW, Barsoumian HB, Xega K, Srivastava G, Kettlun-Leyton C, Nizzero S, Voss T, Riad TS, Wong C, Huang A, Hu Y, Mitchell J, Kim M, Rafiq Z, He K, Sezen D, Hsu E, Masrorpour F, Maleki A, Leuschner C, Cortez MA, Oertle P, Loparic M, Plodinec M, Markman JL, Welsh JW. Enhanced tumor control and survival in preclinical models with adoptive cell therapy preceded by low-dose radiotherapy. Front Oncol 14:1407143, 2024. e-Pub 2024. PMID: 39445067.
      37. Klusman, C, Martin, B, Perez, JD, Barcena, AR, Bernardino, MR, Valentin, ED, Damasco, J, Del Mundo, HC, Court, KA, Godin, B, Canlas, GM, Fowlkes, NW, Bouchard, RR, Cheng, J, Huang, SY, Melancon, MP. Rosuvastatin-Eluting Gold-Nanoparticle-Loaded Perivascular Wrap for Enhanced Arteriovenous Fistula Maturation in a Murine Model. Advanced Fiber Materials 5(6):1986-2001, 2023. e-Pub 2023.
      38. Balema, W, Morton, JE, Larson, R, Li, L, Velasquez, FC, Fowlkes, NW, Krishnamurthy, S, Debeb, BG, Sevick-Muraca, EM, Woodward, W. High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells. Journal of Mammary Gland Biology and Neoplasia 28(1), 2023. e-Pub 2023. PMID: 37801190.
      39. Barcena AJR, Perez JVD, Bernardino MR, Damasco JA, Cortes A, Del Mundo HC, San Valentin EMD, Klusman C, Canlas GM, Heralde FM, Avritscher R, Fowlkes N, Bouchard RR, Cheng J, Huang SY, Melancon MP. Bioresorbable Mesenchymal Stem Cell-Loaded Electrospun Polymeric Scaffold Inhibits Neointimal Hyperplasia Following Arteriovenous Fistula Formation in a Rat Model of Chronic Kidney Disease. Adv Healthc Mater 12(26):e2300960, 2023. e-Pub 2023. PMID: 37395729.
      40. Ito I, Yousef AMG, Chowdhury S, Dickson PN, Naini ZA, White MG, Fleten KG, Flatmark K, Fournier KF, Fowlkes NW, Shen JP. Intraperitoneal paclitaxel is a safe and effective therapeutic strategy for treating mucinous appendiceal adenocarcinoma. Cancer Res 83(19):3184-3191, 2023. e-Pub 2023. PMID: 37433032.
      41. Sun C, Qi Y, Fowlkes N, Lazic N, Su X, Lozano G, Wasylishen AR. The histone chaperone function of Daxx is dispensable for embryonic development. Cell Death Dis 14(8):565, 2023. e-Pub 2023. PMID: 37633949.
      42. Barcena AJR, Perez JVD, Damasco JA, Bernardino MR, San Valentin EMD, Klusman C, Martin B, Cortes A, Canlas GM, Del Mundo HC, Heralde FM, Avritscher R, Fowlkes N, Bouchard RR, Cheng J, Huang SY, Melancon MP. Gold Nanoparticles for Monitoring of Mesenchymal Stem-Cell-Loaded Bioresorbable Polymeric Wraps for Arteriovenous Fistula Maturation. Int J Mol Sci 24(14), 2023. e-Pub 2023. PMID: 37511512.
      43. Napolitano S, Woods M, Lee HM, De Falco V, Martini G, Della Corte CM, Martinelli E, Famiglietti V, Ciardiello D, Anderson A, Fowlkes NW, Villareal OE, Sorokin A, Kanikarla P, Coker O, Morris V, Altucci L, Tabernero J, Troiani T, Ciardiello F, Kopetz S. Antitumor Efficacy of Dual Blockade with Encorafenib + Cetuximab in Combination with Chemotherapy in Human BRAFV600E-Mutant Colorectal Cancer. Clin Cancer Res 29(12):2299-2309, 2023. e-Pub 2023. PMID: 37040395.
      44. Thompson EA, Fowlkes NW, Jacobsen MC, Layman RR, Cressman ENK. Quantitative Dual-Energy CT Image Guidance for Thermochemical Ablation: In Vivo Results in the Rabbit VX2 Model. J Vasc Interv Radiol 34(5):782-789, 2023. e-Pub 2023. PMID: 36539151.
      45. He K, Barsoumian HB, Puebla-Osorio N, Hu Y, Sezen D, Wasley MD, Bertolet G, Zhang J, Leuschner C, Yang L, Kettlun Leyton CS, Fowlkes NW, Green MM, Hettrick L, Chen D, Masrorpour F, Gu M, Maazi H, Revenko AS, Cortez MA, Welsh JW. Inhibition of STAT6 with Antisense Oligonucleotides Enhances the Systemic Antitumor Effects of Radiotherapy and Anti-PD1 in Metastatic Non-Small Cell Lung Cancer. Cancer Immunol Res 11(4):486-500, 2023. e-Pub 2023. PMID: 36700864.
      46. Ito I, Yousef AM, Dickson PN, Naini ZA, White MG, Fleten KG, Flatmark K, Fournier KF, Fowlkes NW, Shen JP. Antitumor activity of intraperitoneal paclitaxel in orthotopic patient-derived xenograft models of mucinous appendiceal adenocarcinoma. bioRxiv, 2023. e-Pub 2023. PMID: 36993681.
      47. Zhao Q, Hu J, Kong L, Jiang S, Tian X, Wang J, Hashizume R, Jia Z, Fowlkes NW, Yan J, Xia X, Yi SF, Dao LH, Masopust D, Heimberger AB, Li S. FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells. Nat Commun 14(1):735, 2023. e-Pub 2023. PMID: 36759517.
      48. San Valentin EM, Damasco JA, Bernardino M, Court KA, Godin B, Canlas GM, Melancon A, Chintalapani G, Jacobsen MC, Norton W, Layman RR, Fowlkes N, Chen SR, Huang SY, Melancon MP. Image-guided deployment and monitoring of a novel tungsten nanoparticleâ€"infused radiopaque absorbable inferior vena cava filter in pigs. bioRxiv, 2023. e-Pub 2023. PMID: 36798362.
      49. Klusman C, Martin B, Perez JVD, Barcena AJR, Bernardino MR, San Valentin EMD, Damasco JA, Mundo HCD, Court K, Godin B, Fowlkes N, Bouchard R, Cheng J, Huang SY, Melancon MP. Rosuvastatin-Eluting Gold Nanoparticle-Loaded Perivascular Implantable Wrap for Enhanced Arteriovenous Fistula Maturation in a Murine Model. bioRxiv, 2023. e-Pub 2023. PMID: 36778365.
      50. Barcena AJR, Perez JVD, Damasco JA, Bernardino MR, San Valentin EMD, Klusman C, Martin B, Cortes A, Canlas G, Del Mundo HC, Heralde FM, Avritscher R, Fowlkes N, Bouchard RR, Cheng J, Huang SY, Melancon MP. Gold Nanoparticles for Monitoring of Mesenchymal Stem Cell-Loaded Bioresorbable Polymeric Wraps for Arteriovenous Fistulas. bioRxiv, 2023. e-Pub 2023. PMID: 36778466.
      51. Pollard AC, Paolillo V, Radaram B, Qureshy S, Li L, Maity T, Wang L, Uddin MN, Wood CG, Karam JA, Pagel MD, Piwnica-Worms D, Millward SW, Fowlkes NW, Norton W, Engel BJ, Pisaneschi F, Zacharias NM. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[18F]Fluoroglutamine. Mol Imaging Biol 24(6):959-972, 2022. e-Pub 2022. PMID: 35732988.
      52. More A, Ito I, Haridas V, Chowdhury S, Gu Y, Dickson P, Fowlkes NW, Shen JP. Oncogene addiction to GNAS in GNASR201 mutant tumors. Oncogene 41(35):4159-4168, 2022. e-Pub 2022. PMID: 35879396.
      53. Pant V, Aryal NK, Xiong S, Chau GP, Fowlkes NW, Lozano G. Alterations of the Mdm2 C-Terminus Differentially Impact Its Function In Vivo. Cancer Res 82(7):1313-1320, 2022. e-Pub 2022. PMID: 35078816.
      54. Damasco JA, Huang SY, Perez JVD, Manongdo JAT, Dixon KA, Williams ML, Jacobsen MC, Barbosa R, Canlas GM, Chintalapani G, Melancon AD, Layman RR, Fowlkes NW, Whitley EM, Melancon MP. Bismuth Nanoparticle and Polyhydroxybutyrate Coatings Enhance the Radiopacity of Absorbable Inferior Vena Cava Filters for Fluoroscopy-Guided Placement and Longitudinal Computed Tomography Monitoring in Pigs. ACS Biomater Sci Eng 8(4):1676-1685, 2022. e-Pub 2022. PMID: 35343679.
      55. Delahoussaye AM, Abi Jaoude J, Green M, Fujimoto TN, Molkentine J, Garcia Garcia CJ, Gay JP, Feng N, Marszalek J, Fowlkes N, Taniguchi CM. Feasibility of administering human pancreatic cancer chemotherapy in a spontaneous pancreatic cancer mouse model. BMC Cancer 22(1):174, 2022. e-Pub 2022. PMID: 35172762.
      56. Hu, J, Yang, Q, Zhang, W, Du, H, Chen, Y, Zhao, Q, Dao, L, Xia, X, Fowlkes, NW, Zhang, Z, Mahadeo, KM, Gorlick, R, Kopetz, S, Dotti, G, Li, S. Cell membrane-Anchored and tumor-Targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors. Journal for immunotherapy of cancer 10(1), 2022. e-Pub 2022. PMID: 35027427.
      57. Kanikarla Marie P, Sorokin AV, Bitner LA, Aden R, Lam M, Manyam G, Woods MN, Anderson A, Capasso A, Fowlkes NW, Overman MJ, Menter DG, Kopetz S. Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts. Front Oncol 12:994333, 2022. e-Pub 2022. PMID: 36212401.
      58. Sen A, Fowlkes NW, Kingsley CV, Kulp AM, Huynh T, Willis BJ, Brewer Savannah KJ, Bordes MCA, Hwang KP, McCulloch MM, Stafford RJ, Contreras A, Reece G, Brock KK. Technical note: Histological validation of anatomical imaging for breast modeling using a novel cryo-microtome. Med Phys 48(11):7323-7332, 2021. e-Pub 2021. PMID: 34559413.
      59. de Cecco BS, Carossino M, Del Piero F, Wakamatsu N, Mitchell MS, Fowlkes NW, Langohr IM. Meningoencephalomyelitis in domestic cats: 3 cases of Pasteurella multocida infection and literature review. J Vet Diagn Invest 33(6):10406387211034484, 2021. e-Pub 2021. PMID: 34301172.
      60. Park J, Tacam MJ, Chauhan G, Cohen EN, Gagliardi M, Iles LR, Ueno NT, Battula VL, Sohn YK, Wang X, Kim HS, Krishnamurthy S, Fowlkes NW, Green MM, Bartholomeusz GA, Tripathy D, Reuben JM, Bartholomeusz C. Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression. Breast Cancer Res Treat 189(2):333-345, 2021. e-Pub 2021. PMID: 34241740.
      61. Aslan B, Kismali G, Chen LS, Iles LR, Mahendra M, Peoples M, Gagea M, Fowlkes NW, Zheng X, Wang J, Vellano CP, Marszalek JR, Bertilaccio MTS, Gandhi V. Development and characterization of prototypes for in vitro and in vivo mouse models of ibrutinib-resistant CLL. Blood Adv 5(16):3134-3146, 2021. e-Pub 2021. PMID: 34424317.
      62. Kerbauy LN, Marin ND, Kaplan M, Banerjee PP, Berrien-Elliott MM, Becker-Hapak M, Basar R, Foster M, Garcia Melo L, Neal CC, McClain E, Daher M, Nunez Cortes AK, Desai S, Inng Lim FW, Mendt MC, Schappe T, Li L, Shaim H, Shanley M, Ensley EL, Uprety N, Wong P, Liu E, Ang SO, Cai R, Nandivada V, Mohanty V, Miao Q, Shen Y, Baran N, Fowlkes NW, Chen K, Muniz-Feliciano L, Champlin RE, Nieto YL, Koch J, Treder M, Fischer W, Okamoto OK, Shpall EJ, Fehniger TA, Rezvani K. Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies. Clin Cancer Res 27(13):3744-3756, 2021. e-Pub 2021. PMID: 33986022.
      63. Shaim H, Shanley M, Basar R, Daher M, Gumin J, Zamler DB, Uprety N, Wang F, Huang Y, Gabrusiewicz K, Miao Q, Dou J, Alsuliman A, Kerbauy LN, Acharya S, Mohanty V, Mendt M, Li S, Lu J, Wei J, Fowlkes NW, Gokdemir E, Ensley EL, Kaplan M, Kassab C, Li L, Ozcan G, Banerjee PP, Shen Y, Gilbert AL, Jones CM, Bdiwi M, Nunez-Cortes AK, Liu E, Yu J, Imahashi N, Muniz-Feliciano L, Li Y, Hu J, Draetta G, Marin D, Yu D, Mielke S, Eyrich M, Champlin RE, Chen K, Lang FF, Shpall EJ, Heimberger AB, Rezvani K. Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells. J Clin Invest 131(14), 2021. e-Pub 2021. PMID: 34138753.
      64. Wu M, Xia X, Hu J, Fowlkes NW, Li S. WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression. Nat Commun 12(1):3500, 2021. e-Pub 2021. PMID: 34108491.
      65. Lulla AR, Akli S, Karakas C, Ha MJ, Fowlkes NW, Mitani Y, Bui T, Wang J, Rao X, Hunt KK, Meijer L, El-Naggar AK, Keyomarsi K. LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers. Oncogenesis 10(5):40, 2021. e-Pub 2021. PMID: 33990543.
      66. Konen JM, Rodriguez BL, Padhye A, Ochieng JK, Gibson L, Diao L, Fowlkes NW, Fradette JJ, Peng DH, Cardnell RJ, Kovacs JJ, Wang J, Byers LA, Gibbons DL. Dual inhibition of MEK and AXL targets tumor cell heterogeneity and prevents resistant outgrowth mediated by the epithelial-to-mesenchymal transition in NSCLC. Cancer Res 81(5):1398-1412, 2021. e-Pub 2021. PMID: 33402388.
      67. Daher M, Basar R, Gokdemir E, Baran N, Uprety N, Nunez Cortes AK, Mendt M, Kerbauy LN, Banerjee PP, Shanley M, Imahashi N, Li L, FLWI L, Fathi M, Rezvan A, Mohanty V, Shen Y, Shaim H, Lu J, Ozcan G, Ensley E, Kaplan M, Nandivada V, Bdiwi M, Acharya S, Xi Y, Wan X, Mak D, Liu E, Jiang XR, Ang S, Muniz-Feliciano L, Li Y, Wang J, Kordasti S, Petrov N, Varadarajan N, Marin D, Brunetti L, Skinner RJ, Lyu S, Silva L, Turk R, Schubert MS, Rettig GR, McNeill MS, Kurgan G, Behlke MA, Li H, Fowlkes NW, Chen K, Konopleva M, Champlin RE, Shpall EJ, Rezvani K. Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells. Blood 137(5):624-636, 2021. e-Pub 2021. PMID: 32902645.
      68. Uche IK, Fowlkes NW, Vu L, Watanabe T, Carossino M, Nabi R, Del Piero F, Rudd JS, Kousoulas KG, Rider PJF. The Novel Oncolytic Herpes Simplex Virus Type-1 (HSV-1) VC2 Promotes Long-lasting, Systemic Anti-melanoma Tumor Immune Responses and Increased Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model. J Virol 95(3), 2021. e-Pub 2021. PMID: 33177208.
      69. Janke LJ, Imai DM, Tillman H, Doty R, Hoenerhoff MJ, Xu JJ, Freeman ZT, Allen P, Fowlkes NW, Iacobucci I, Dickerson K, Mullighan CG, Vogel P, Rehg JE. Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts. Vet Pathol 58(1):300985820970144, 2021. e-Pub 2021. PMID: 33208054.
      70. Mendt M, Daher M, Basar R, Shanley M, Kumar B, Wei Inng FL, Acharya S, Shaim H, Fowlkes NW, Tran JP, Gokdemir E, Uprety N, Nunez-Cortes AK, Ensley E, Mai T, Kerbauy LN, Melo-Garcia L, Lin P, Shen Y, Mohanty V, Lu J, Li S, Nandivada V, Wang J, Banerjee P, Reyes-Silva F, Liu E, Ang S, Gilbert A, Li Y, Wan X, Gu J, Zhao M, Baran N, Muniz-Feliciano L, Wilson J, Kaur I, Gagea M, Konopleva M, Marin D, Tang G, Chen K, Champlin R, Rezvani K, Shpall EJ. Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD. Front Immunol 12:631353, 2021. e-Pub 2021. PMID: 34017325.
      71. Moyer SM, Wasylishen AR, Qi Y, Fowlkes N, Su X, Lozano G. p53 drives a transcriptional program that elicits a non-cell-autonomous response and alters cell state in vivo. Proc Natl Acad Sci U S A 117(38):23663-23673, 2020. e-Pub 2020. PMID: 32900967.
      72. Basar R, Daher M, Uprety N, Gokdemir E, Alsuliman A, Ensley E, Ozcan G, Mendt M, Hernandez Sanabria M, Kerbauy LN, Nunez Cortes AK, Li L, Banerjee PP, Muniz-Feliciano L, Acharya S, Fowlkes N, Lu J, Li S, Mielke S, Kaplan M, Nandivada V, Bdaiwi M, Kontoyiannis AD, Li Y, Liu E, Ang S, Marin D, Brunetti L, Gundry MC, Turk R, Schubert MS, Rettig GR, McNeill MS, Kurgan G, Behlke MA, Champlin R, Shpall EJ, Rezvani K. Large-scale GMP-compliant CRISPR-Cas9-mediated deletion of the glucocorticoid receptor in multivirus-specific T cells. Blood Adv 4(14):3357-3367, 2020. e-Pub 2020. PMID: 32717029.
      73. Casal RF, Schwalk AJ, Fowlkes N, Aburto RR, Norton W, Dixon KA, Lin S, Shaitelman SF, Chintalapani G, Hill L. Endobronchial ultrasound-guided injection of NBTXR3 radio enhancing nanoparticles into mediastinal and hilar lymph nodes: a swine model to evaluate feasibility, injection technique, safety, nanoparticle retention and dispersion. J Thorac Dis 12(5):2317-2324, 2020. e-Pub 2020. PMID: 32642136.
      74. Fowlkes N, Clemons K, Rider PJ, Subramanian R, Wakamatsu N, Langohr I, Kousoulas KG. Factors Affecting Growth Kinetics and Spontaneous Metastasis in the B16F10 Syngeneic Murine Melanoma Model. Comp Med 69(1):1-7, 2019. e-Pub 2019. PMID: 30563585.
      75. Leissinger MK, McCauley C, Fowlkes N, Grasperge BJ. What is your diagnosis? Nasal lesion in a horse. Vet Clin Pathol 46(2):361-362, 2017. e-Pub 2017. PMID: 28249099.
      76. Le Donne V, Crossland N, Brandão J, Sokolova Y, Fowlkes N, Nevarez JG, Langohr IM, Gaunt SD. Nannizziopsis guarroi infection in 2 Inland Bearded Dragons (Pogona vitticeps): clinical, cytologic, histologic, and ultrastructural aspects. Vet Clin Pathol 45(2):368-375, 2016. e-Pub 2016. PMID: 27010762.
      77. Evans D, Fowlkes N. Renal leiomyosarcoma in a cat. J Vet Diagn Invest 28(3):315-8, 2016. e-Pub 2016. PMID: 26975352.
      78. Sumner JP, Pucheu-Haston CM, Fowlkes N, Merchant S. Dorsal skin necrosis secondary to a solar-induced thermal burn in a brown-coated dachshund. Can Vet J 57(3):305-8, 2016. e-Pub 2016. PMID: 26933270.
      79. Leissinger MK, Garber JB, Fowlkes N, Grooters AM, Royal AB, Gaunt SD. Mycobacterium fortuitum lipoid pneumonia in a dog. Vet Pathol 52(2):356-9, 2015. e-Pub 2015. PMID: 24788402.
      80. Doss GA, Nevarez JG, Fowlkes N, da Cunha AF. Evaluation of metomidate hydrochloride as an anesthetic in leopard frogs (Rana pipiens). J Zoo Wildl Med 45(1):53-9, 2014. e-Pub 2014. PMID: 24712162.
      81. Brandão J, Woods S, Fowlkes N, Leissinger M, Blair R, Pucheu-Haston C, Johnson J, Elster Phillips C, Tully T. Disseminated histoplasmosis (Histoplasma capsulatum) in a pet rabbit: case report and review of the literature. J Vet Diagn Invest 26(1):158-62, 2014. e-Pub 2014. PMID: 24452788.
      82. Gupta A, Garber J, Fowlkes N, Rademacher N, Shiomitsu K, Evans DE, Gaunt SD. What is your diagnosis? Abdominal fluid from a dog. Vet Clin Pathol 42(1):113-4, 2013. e-Pub 2013. PMID: 23083469.
      83. Gumber S, Fowlkes N, Cho DY. Disseminated sclerosing peritoneal mesothelioma in a dog. J Vet Diagn Invest 23(5):1046-50, 2011. e-Pub 2011. PMID: 21908373.
      84. Scollard DM, Chaduvula MV, Martinez A, Fowlkes N, Nath I, Stryjewska BM, Kearney MT, Williams DL. Increased CXC ligand 10 levels and gene expression in type 1 leprosy reactions. Clin Vaccine Immunol 18(6):947-53, 2011. e-Pub 2011. PMID: 21508169.

      Review Articles

      1. Kanikarla Marie P, Fowlkes NW, Afshar-Kharghan V, Martch SL, Sorokin A, Shen JP, Morris VK, Dasari A, You N, Sood AK, Overman MJ, Kopetz S, Menter DG. The Provocative Roles of Platelets in Liver Disease and Cancer. Front Oncol 11:643815, 2021. e-Pub 2021. PMID: 34367949.

      Other Articles

      1. Cressman, EN, Raj, M, Seeley, E, Fowlkes, NW, Habibollahi, P Recent Developments and Future Directions in Image-Guided Chemistry. Journal of Vascular and Interventional Radiology 36(12):1894-1898, 2025. PMID: 41276369.
      2. Nieto, Y, Banerjee, PP, Kaur, I, Basar, R, Li, YE, Daher, M, Rafei, H, Kerbauy, LN, Kaplan, M, Marin, D, Griffin, L, Barnett, M, Bassett Jr, R, Uprety, N, Shrestha, R, Silva, FR, Islam, S, Ganesh, C, Borneo, Z, Ramdial, JL, Ramirez, A, Hosing, C, Alousi, AM, Popat, UR, Qazilbash, MH, Ahmed, S, Iyer, SP, Sainz, TP, Vega Vazquez, F, Fowlkes, NW, Alexis, K, Emig, M, Harstrick, A, Overesch, A, Shpall, E, Rezvani, K Correction to. Nature medicine 31(8):2816, 2025. PMID: 40571757.

      Abstracts

      1. Fowlkes NW. Transcriptomic, Proteomic, And Genomic Mutational Fraction Differences Based On HPV Status Observed In Patient Derived Xenograft Models Of Penile Squamous Cell Carcinoma. Urology, 2024. e-Pub 2024.
      2. Villarreal OE, Lee HM, Tran H, Machado A, Alshenaifi J, Wong CW, Coker O, Minelli R, Peoples M, Martinez AH, Fowlkes N, Kanikarla P, Lin K, Bristow C, Viale A, Marszalek JR, Shen JP, Kopetz S. ASCL2+ tumor cells modulate the response of colorectal cancer to MAPK targeting therapy. Cancer Research 84(7), 2024. e-Pub 2024.
      3. Tan AW, Mughees M, Woodward WA, Tripathy D, Fowlkes N, Bartholomeusz C. PEA-15 phosphorylation mediates pro-tumor effects by promoting β-catenin activity in TNBC. Cancer Research, 2024. e-Pub 2024.
      4. Fowlkes NW, Cho KS, Soeung M, Anderson A, Alshenaifi J, Manyam G, Villareal O, Davis J, Norton W, Gao S, Bristow C, Carbone F, Napolitano S, Coker O, Khanduri I, Huang J, Maru DM, Pilato MD, Sun R, Wang L, Menter DG, Genovese G, Draetta G, Fowlkes N, Kopetz S. Anti-CSF1R antibody monotherapy inhibits minimal residual disease in a novel immunocompetent murine colorectal cancer metastasis model. Cancer Research 84(6):1168, 2024. e-Pub 2024.
      5. Cortes AC, Minamiguchi K, Kostan H, Stenkamp MS, Anfossi S, Fowlkes NW, Avritcsher R. Non-invasive monitoring of tumor biomechanics and implications for immunotherapy in HCC. Cancer Research 84(6):5547, 2024. e-Pub 2024.
      6. Smetanick D, Stolley D, Fuentes D, Fowlkes NW, Shakoor F, Stenkamp MS, Hicks S, Parrish S, Cressman E. Volumetric CT Assessment of In Situ Induced Hepatic Lesions of an Oncopig Model. Vacular and Interventional Radiology 35(3):S209, 2024. e-Pub 2024.
      7. Pattalachinti VK, Pattalachinti VK, Ito I, Ito I, Chowdhury S, Chowdhury S, Yousef A, Yousef A, Gu Y, Gu Y, Gunes BB, Gunes BB, Salle ER, Salle ER, Taggart MW, Taggart MW, Fournier K, Fournier K, Fowlkes NW, Fowlkes NW, Shen JP, Shen JP. Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Cancer Research 22(4):329-336, 2024. e-Pub 2024.
      8. Puebla N, Srivastava G, Nizzero S, Fowlkes NW, Barsoumian H, Hu Y, Leuschner C, Riad T, Loparic M, Plodinec M, Welsh J. Enhanced tumor control and survival in solid tumor models following combined low dose radiotherapy and T cell therapy. Cancer Research 84(6):97, 2024. e-Pub 2024.
      9. Abana CO, Palmiero AN, Liu K, Green MM, Li Z, Harris L, Mayor S, Samuel KQ, Younkin RA, Moore EJ, Norton W, Swain J, Fowlkes NW, Koong AC, Woodward WA, Taniguchi CM, Beddar S, Mitra D, Schueler E, Lin SH. Subacute Cutaneous Toxicity with Single-Fraction Electron FLASH RT in Yorkshire Swine. International Journal of Radiation Oncology, Biology, Physics, 117(2):S10-S11, 2023. e-Pub 2023.
      10. Green MM, Fujimoto T, Taniguchi C, Fowlkes NW. Modeling age-related changes in the tumor microenvironment in an orthotopic immunocompetent murine pancreatic cancer model-a novel approach. Cancer Research 83(7_Supplement):5191-5191, 2023. e-Pub 2023.
      11. Cortes AC, Minamiguchi K, Costa Lopez PLD, Anfossi S, Williams Malea L, Stenkamp MS, Avritscher R, Fowlkes NW. Vimentin content associated with shear wave speed in hepatocellular carcinoma: Non-invasive identification of more aggressive tumor phenotypes. Cancer Research 83(7_Supplement):5852-5852, 2023. e-Pub 2023.
      12. Mohamed AM, Soeung M, Alshenaifi J, Fowlkes NW, Manyam G, Davis J, Anderson A, Norton W, Deem AK, Gao S, Khanduri I, Bistow C, Carbone F, Napolitano S, Huang J, Maru DM, Menter DG, Draetta GF, Genovese G, Kopetz S. Recapitulating metastatic colorectal cancer in somatic mutation models for investigating the tumor immune microenvironment in minimal residual disease. Cancer Research 83(7_Supplement):77-77, 2023. e-Pub 2023.
      13. Barcena J, Perez J, Bernardino M, Damasco J, Valentin E, Mundo H, Cortes A, Canlas G, Chen J, Avritscher R, Fowlkes NW, Huang S, Melancon M. Bioresorbable Mesenchymal Stem Cell-Loaded Electrospun Polymeric Scaffold Inhibits Neointimal Hyperplasia in a Rat Model of Arteriovenous Fistula. Journal of Vascular and Interventional Radiology 34(3):S16-17, 2023. e-Pub 2023.
      14. Balema W, Krishnamurthy S, Lawrence A, Rodriguez M, Larson R, Fowlkes NW, Ueno NT, Woodward W. CCR7 expression in Inflammatory breast cancer. Cancer Research 83(5_Supplement):P2-26-15-P2-26-15, 2023. e-Pub 2023.
      15. Valentin E, Damasco J, Bernardino M, Honegger S, Court K, Godin B, Canlas G, Chintalapani G, Norton W, Chen S, Fowlkes NW, Huang S, Melancon M. In Vivo Imaging of Novel Tungsten Nanoparticle and Polymer-Infused Resorbable Inferior Vena Cava Filters in Porcine Model. Journal of Vascular and Interventional Radiology 34(3):S123-S124, 2023. e-Pub 2023.
      16. Akli S, Lulla AR, Saenz FR, Wang F, Fowlkes NW, Bui T, Wang Y, Mastoraki S, Ha MJ, Hunt KK, Keyomarsi K. Aurora kinase is an actionable target in low molecular weight cyclin E induced mammary tumors. Cancer Research 82(12_Supplement):2592, 2022. e-Pub 2022.
      17. Lulla AR, Akli S, Warma LD, Fowlkes NW, Hunt KK, Rao X, Wang J, Watowich SS, Keyomarsi K. Neutrophil elastase (NE) inhibition enhances metastasis free survival by altering regulation of tumor intrinsic cytoskeletal and cellular adhesion pathways in murine breast cancer models. Cancer Research 82(12_Supplement):264, 2022. e-Pub 2022.
      18. Mastoraki S, Lulla AR, Schneider S, Clise-Dwyer K, Green MM, Fowlkes NW, Hunt KK, Watowich SS, Keyomarsi K. LMW-E induction and crosstalk with immune cells potentiates local immune responses leading to an immunosuppressive microenvironment at the early stages of breast tumorigenesis in mouse models. Cancer Research 82(12_Supplement):1348, 2022. e-Pub 2022.
      19. Segarra LA, Zacharias NM, Pieretti A, Alaniz A, Maity T, Martinez S, Rao P, Fowlkes NW, Chahoud J, Lu X, Ferrer MM, Wood C, Pettaway C. Establishment of patient-derived xenografts in penile cancer. Cancer Research 82(12_Supplement):3111, 2022. e-Pub 2022.
      20. Uche IK, Fowlkes NW, Vu L, Watanabe T, Carossino M, Nabi R, Piero FD, Rudd JS, Kousoulas KG, Rider PJ. VC2 Oncolytic Virotherapy Induces Robust Systemic Anti-Tumor Immunity and Increases Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model. Journal of Clinical and Translational Science 5(s1):13-14, 2021. e-Pub 2021.
      21. Hu JM, Zhang WD, Xia XQ, Yang Q, Chen YH, Fowlkes NW, Livingston JA, Zhang ZT, Mahadeo KM, Gill JB, Dotti G, Kopetz S, Gorlick R, Li SL. CRS free T cell therapy: T cell membrane anchored and tumor targeted IL12 (ATTIL12)-T cell therapy eliminates large tumors, overcomes heterogeneity, and avoids adverse effects. Journal of Immunology 204(1), 2020. e-Pub 2020.
      22. Kerbauy L, Marin N, Kaplan M, Banerjee P, Berrien-Elliott M, Becker-Hapak M, Basar R, Foster M, Melo LG, Neal C, McClain E, Daher M, Nunez Cortes AK, Desai S, Inng Lim FW, Mendt MC, Schappe T, Li L, Shaim H, Sanabria MH, Wong P, Liu E, Ang S, Cai R, Nandivada V, Mohanty V, Shen Y, Baran N, Fowlkes NW, Chen K, Muniz-Feliciano L, Koch J, Treder M, Fischer W, Okamoto OK, Nieto Y, Champlin R, Shpall E, Fehniger T, Rezvani K. AFM13-Targeted Blood and Cord-Blood-Derived Memory-Like NK Cells as Therapy for CD30+ Malignancies. Journal for ImmunoTherapy of Cancer 8(Suppl 3), 2020. e-Pub 2020.
      23. Fowlkes NW, Swain J, Gagea M, Lockworth C, Tinkey P, Jensen V, Whitley EM. Cutaneous and Gastrointestinal Dysbiosis in Immunodeficient Mice. FASEB Journal 33(1S), 2019. e-Pub 2019.
      24. Scollard DM, Fowlkes NW, Martinez A, Chaduvula M, Nath I, Strjewska B, Williams D. Reversal Reaction in Leprosy is Associated with Increased CXCL10 Production. The FASEB Journal 23:1003.12-1003.12, 2009. e-Pub 2009.
      25. Scollard DM, Martinez A, Chaduvula M, Fowlkes N, Nath I, Stryjewska B, Williams DL. Increased CXCL10 Is Associated with Reversal Reaction in Leprosy. Laboratory Investigation 89:297A-297A, 2009. e-Pub 2009.
      Read More
      Less

      Patient Reviews


      CV information above last modified September 04, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Care Centers and Clinics

      • Departments and Divisions

      • Labs

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top